Chopra, B KKazal, H LMittal, P KSibia, S S1991-03-012009-05-291991-03-012009-05-291991-03-01Chopra BK, Kazal HL, Mittal PK, Sibia SS. Esophagitis: clinical and endoscopic assessment of sucralfate therapy. Indian Journal of Medical Sciences. 1991 Mar; 45(3): 55-7http://imsear.searo.who.int/handle/123456789/67967Twenty patients with endoscopically proved reflux esophagitis were studied. Each patient was given 1 gm sucralfate 4 times a day for 6 weeks. Clinical and endoscopic assessment of the effects of sucralfate on reflux esophagitis was done. 50% patients became asymptomatic and 60% healed endoscopically. The drug was well tolerated. We conclude that sucralfate is an effective and well tolerated drug for treatment of reflux esophagitis.engAdultEsophagitis, Peptic --diagnosisEsophagoscopyHumansSucralfate --adverse effectsJournal Article